The impact of fluoroquinolone resistance of Gram-negative bacteria in respiratory secretions on the outcome of lung transplant (non-cystic fibrosis) recipients.
Shteinberg, Michal
The impact of fluoroquinolone resistance of Gram-negative bacteria in respiratory secretions on the outcome of lung transplant (non-cystic fibrosis) recipients. [electronic resource] - Clinical transplantation - 884-90 p. digital
Publication Type: Journal Article
1399-0012
10.1111/j.1399-0012.2012.01665.x doi
Anti-Bacterial Agents--pharmacology
Bronchiolitis Obliterans--drug therapy
Drug Resistance, Microbial
Female
Fluoroquinolones--pharmacology
Follow-Up Studies
Gram-Negative Bacteria--isolation & purification
Gram-Positive Bacterial Infections--drug therapy
Humans
Immunosuppression Therapy
Lung Transplantation--adverse effects
Male
Middle Aged
Postoperative Complications
Prognosis
Respiratory System--drug effects
Retrospective Studies
Risk Factors
Survival Rate
The impact of fluoroquinolone resistance of Gram-negative bacteria in respiratory secretions on the outcome of lung transplant (non-cystic fibrosis) recipients. [electronic resource] - Clinical transplantation - 884-90 p. digital
Publication Type: Journal Article
1399-0012
10.1111/j.1399-0012.2012.01665.x doi
Anti-Bacterial Agents--pharmacology
Bronchiolitis Obliterans--drug therapy
Drug Resistance, Microbial
Female
Fluoroquinolones--pharmacology
Follow-Up Studies
Gram-Negative Bacteria--isolation & purification
Gram-Positive Bacterial Infections--drug therapy
Humans
Immunosuppression Therapy
Lung Transplantation--adverse effects
Male
Middle Aged
Postoperative Complications
Prognosis
Respiratory System--drug effects
Retrospective Studies
Risk Factors
Survival Rate